The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Escherichia coli in Europe: An Overview
Open accessAbstract
Escherichia coli remains one of the most frequent causes of several common bacterial infections in humans and animals. E. coli is the prominent cause of enteritis, urinary tract infection, septicaemia and other clinical infections, such as neonatal meningitis. E. coli is also prominently associated with diarrhoea in pet and farm animals. The therapeutic treatment of E. coli infections is threatened by the emergence of antimicrobial resistance. The prevalence of multidrug-resistant E. coli strains is increasing worldwide principally due to the spread of mobile genetic elements, such as plasmids. The rise of multidrug-resistant strains of E. coli also occurs in Europe. Therefore, the spread of resistance in E. coli is an increasing public health concern in European countries. This paper summarizes the current status of E. coli strains clinically relevant in European countries. Furthermore, therapeutic interventions and strategies to prevent and control infections are presented and discussed. The article also provides an overview of the current knowledge concerning promising alternative therapies against E. coli diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Magiorakos, A.-P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G., Olsson-Liljequist, B., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03570.x · Cited by 14,449
Kaper, J. B., Nataro, J. P., & Mobley, H. L. T. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro818 · Cited by 5,583
Carbapenemases: the Versatile β-Lactamases
Queenan, A. M., & Bush, K. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-07 · Cited by 2,499
Global Spread of Carbapenemase-producing Enterobacteriaceae
Nordmann, P., Naas, T., & Poirel, L. (2011) · Emerging Infectious Diseases · doi:10.3201/eid1710.110655 · Cited by 2,378
Designing antimicrobial peptides: form follows function
Fjell, C. D., Hiss, J. A., Hancock, R. E. W., & Schneider, G. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3591 · Cited by 2,035
Multidrug Resistance in Bacteria
Nikaido, H. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.082907.145923 · Cited by 1,682
Sulakvelidze, A., Alavidze, Z., & Morris, J. G. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.649-659.2001 · Cited by 1,566
Multidrug-resistance efflux pumps ? not just for resistance
Piddock, L. J. V. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1464 · Cited by 1,522
Hospital-Acquired Infections Due to Gram-Negative Bacteria
Peleg, A. Y., & Hooper, D. C. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0904124 · Cited by 1,495
Johnson, J. R., & Stell, A. L. (2000) · The Journal of Infectious Diseases · doi:10.1086/315217 · Cited by 1,269
Epidemiology of Escherichia coli O157:H7 Outbreaks, United States, 1982–2002
Rangel, J. M., Sparling, P. H., Crowe, C., Griffin, P. M., & Swerdlow, D. L. (2005) · Emerging Infectious Diseases · doi:10.3201/eid1104.040739 · Cited by 1,263
The CTX-M β-lactamase pandemic
Cantón, R., & Coque, T. M. (2006) · Current Opinion in Microbiology · doi:10.1016/j.mib.2006.08.011 · Cited by 1,147
Probiotics, Prebiotics, and Synbiotics
de Vrese, M., & Schrezenmeir, J. (2008) · Advances in Biochemical Engineering/Biotechnology · doi:10.1007/10_2008_097 · Cited by 1,028
Phage treatment of human infections
Abedon, S. T., Kuhl, S. J., Blasdel, B. G., & Kutter, E. M. (2011) · Bacteriophage · doi:10.4161/bact.1.2.15845 · Cited by 980
The worldwide emergence of plasmid-mediated quinolone resistance
Robicsek, A., Jacoby, G. A., & Hooper, D. C. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70599-0 · Cited by 966
Qadri, F., Svennerholm, A.-M., Faruque, A. S. G., & Sack, R. B. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.3.465-483.2005 · Cited by 956
CTX-M: changing the face of ESBLs in Europe
Livermore, D. M., Canton, R., Gniadkowski, M., Nordmann, P., Rossolini, G. M., Arlet, G., Ayala, J., Coque, T. M., Kern-Zdanowicz, I., Luzzaro, F., et al. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl483 · Cited by 927
Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe
Cantón, R., Akóva, M., Carmeli, Y., Giske, C. G., Glupczynski, Y., Gniadkowski, M., Livermore, D. M., Miriagou, V., Naas, T., Rossolini, G. M., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03821.x · Cited by 883
Resistance in Gram-Negative Bacteria: Enterobacteriaceae
Paterson, D. L. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.03.013 · Cited by 874
Combination Therapy for Treatment of Infections with Gram-Negative Bacteria
Tamma, P. D., Cosgrove, S. E., & Maragakis, L. L. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05041-11 · Cited by 836
Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain
Rogers, B. A., Sidjabat, H. E., & Paterson, D. L. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq415 · Cited by 716
The evolving threat of antimicrobial resistance: Options for action
Kapi, A. (2014) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 714
Ewers, C., Bethe, A., Semmler, T., Guenther, S., & Wieler, L. H. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03850.x · Cited by 677
Combination approaches to combat multidrug-resistant bacteria
Worthington, R. J., & Melander, C. (2013) · Trends in Biotechnology · doi:10.1016/j.tibtech.2012.12.006 · Cited by 625 · cited 1×
“The use of two or more antimicrobial agents simultaneously is a common practice for the treatment of several infectious, such as malaria, HIV and tuberculosis [94].”
BackgroundMechanisms of quinolone resistance in Escherichia coli and Salmonella: Recent developments
Hopkins, K. L., Davies, R. H., & Threlfall, E. J. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.02.006 · Cited by 557
Phage display: Concept, innovations, applications and future
Pande, J., Szewczyk, M. M., & Grover, A. K. (2010) · Biotechnology Advances · doi:10.1016/j.biotechadv.2010.07.004 · Cited by 492
Mechanisms of fluoroquinolone resistance
Hooper, D. C. (1999) · Drug Resistance Updates · doi:10.1054/drup.1998.0068 · Cited by 488
Bacteriophages as potential new therapeutics to replace or supplement antibiotics
Kutateladze, M., & Adamia, R. (2010) · Trends in Biotechnology · doi:10.1016/j.tibtech.2010.08.001 · Cited by 483
Pathogenomics of the Virulence Plasmids of Escherichia coli
Johnson, T. J., & Nolan, L. K. (2009) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00015-09 · Cited by 453
Bacteriophage endolysins: A novel anti-infective to control Gram-positive pathogens
Fischetti, V. A. (2010) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2010.04.002 · Cited by 438
Rodriguez-Siek, K. E., Giddings, C. W., Doetkott, C., Johnson, T. J., Fakhr, M. K., & Nolan, L. K. (2005) · Microbiology · doi:10.1099/mic.0.27499-0 · Cited by 432
Schito, G. C., Naber, K. G., Botto, H., Palou, J., Mazzei, T., Gualco, L., & Marchese, A. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.04.012 · Cited by 421
Hassan, M., Kjos, M., Nes, I. F., Diep, D. B., & Lotfipour, F. (2012) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2012.05338.x · Cited by 402 · cited 2×
“Antimicrobial peptides (AMPs) are an abundant and diverse group of molecules that are produced by eukaryotic and prokaryotic organisms or encoded by phages [96,97,115].”
BackgroundJohnson, T. J., Kariyawasam, S., Wannemuehler, Y., Mangiamele, P., Johnson, S. J., Doetkott, C., Skyberg, J. A., Lynne, A. M., Johnson, J. R., & Nolan, L. K. (2007) · Journal of Bacteriology · doi:10.1128/jb.01726-06 · Cited by 367
Bacteriophages and Their Role in Food Safety
Sillankorva, S. M., Oliveira, H., & Azeredo, J. (2012) · International Journal of Microbiology · doi:10.1155/2012/863945 · Cited by 329
Da Costa, P., Loureiro, L., & Matos, A. (2013) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph10010278 · Cited by 325
Probiotics, Prebiotics and Synbiotics
Hawrelak, J. (2007) · eCite Digital Repository (University of Tasmania) · Cited by 320
Multidrug resistant commensal Escherichia coli in animals and its impact for public health
Szmolka, A., & Nagy, B. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00258 · Cited by 314
Bacteriophages and their implications on future biotechnology: a review
Haq, I. U., Chaudhry, W. N., Akhtar, M. N., Andleeb, S., & Qadri, I. (2012) · Virology Journal · doi:10.1186/1743-422x-9-9 · Cited by 304
Korzeniewska, E., Korzeniewska, A., & Harnisz, M. (2013) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2013.01.014 · Cited by 302
Parisien, A., Allain, B., Zhang, J., Mandeville, R., & Lan, C. Q. (2007) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2007.03498.x · Cited by 300
The role of international travel in the worldwide spread of multiresistant Enterobacteriaceae
van der Bij, A. K., & Pitout, J. D. D. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks214 · Cited by 292
CTX-M: changing the face of ESBLs in the UK
Livermore, D. M., & Hawkey, P. M. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki239 · Cited by 278
A systematic review of ETEC epidemiology focusing on colonization factor and toxin expression
Isidean, S. D., Riddle, M. S., Savarino, S. J., & Porter, C. K. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.06.084 · Cited by 273
Evolutionary consequences of antibiotic use for the resistome, mobilome and microbial pangenome
Gillings, M. R. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00004 · Cited by 264
Neonatal Bacterial Meningitis: 444 Cases in 7 Years
Gaschignard, J., Levy, C., Romain, O., Cohen, R., Bingen, E., Aujard, Y., & Boileau, P. (2011) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181fab1e7 · Cited by 264
Moriel, D. G., Bertoldi, I., Spagnuolo, A., Marchi, S., Rosini, R., Nesta, B., Pastorello, I., Corea, V. A. M., Torricelli, G., Cartocci, E., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915077107 · Cited by 261
Enteroaggregative Escherichia coli
Nataro, J. P., Steiner, T., & Guerrant, R. L. (1998) · Emerging Infectious Diseases · doi:10.3201/eid0402.980212 · Cited by 249
Pathogenesis of Afa/Dr Diffusely Adhering Escherichia coli
Servin, A. L. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.2.264-292.2005 · Cited by 249
The enemy within us: lessons from the 2011 European Escherichia coli O104:H4 outbreak
Karch, H., Denamur, E., Dobrindt, U., Finlay, B. B., Hengge, R., Johannes, L., Ron, E. Z., Tønjum, T., Sansonetti, P. J., & Vicente, M. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201201662 · Cited by 242
Tivendale, K. A., Logue, C. M., Kariyawasam, S., Jordan, D., Hussein, A., Li, G., Wannemuehler, Y., & Nolan, L. K. (2010) · Infection and Immunity · doi:10.1128/iai.00347-10 · Cited by 216
Developing vaccines in the era of genomics: a decade of reverse vaccinology
Seib, K. L., Zhao, X., & Rappuoli, R. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03939.x · Cited by 215
Galimand, M., Sabtcheva, S., Courvalin, P., & Lambert, T. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.2949-2953.2005 · Cited by 209
Antimicrobial resistance of Escherichia coli and therapeutic implications
von Baum, H., & Marre, R. (2005) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2005.07.002 · Cited by 207
Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine
Brumbaugh, A. R., & Mobley, H. L. (2012) · Expert Review of Vaccines · doi:10.1586/erv.12.36 · Cited by 202
Plasmid-Mediated Resistance in Enterobacteriaceae: Changing Landscape and Implications for Therapy
Schultsz, C., & Geerlings, S. E. (2011) · Drugs · doi:10.2165/11597960-000000000-00000 · Cited by 188
Phylogenetic diversity of Escherichia coli strains producing NDM-type carbapenemases
Mushtaq, S., Irfan, S., Sarma, J. B., Doumith, M., Pike, R., Pitout, J., Livermore, D. M., & Woodford, N. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr226 · Cited by 182
Bacteriophage virion-associated peptidoglycan hydrolases: potential new enzybiotics
Rodríguez-Rubio, L., Martínez, B., Donovan, D. M., Rodríguez, A., & García, P. (2013) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2012.723675 · Cited by 173
Genetic support and diversity of acquired extended-spectrum β-lactamases in Gram-negative rods
Poirel, L., Bonnin, R. A., & Nordmann, P. (2012) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2012.02.008 · Cited by 173
Al-Abri, S. S., Beeching, N. J., & Nye, F. J. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70139-0 · Cited by 173
Pitout, J. D. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.110 · Cited by 161
Bacteriophages for prophylaxis and therapy in cattle, poultry and pigs
Johnson, R. P., Gyles, C. L., Huff, W. E., Ojha, S., Huff, G. R., Rath, N. C., & Donoghue, A. M. (2008) · Animal Health Research Reviews · doi:10.1017/s1466252308001576 · Cited by 161
Adherent-invasive Escherichia coli: a putative new E. coli pathotype associated with Crohn's disease
Darfeuille-Michaud, A. (2002) · International Journal of Medical Microbiology · doi:10.1078/1438-4221-00201 · Cited by 158
Probiotics, Enteric and Diarrheal Diseases, and Global Health
Preidis, G. A., Hill, C., Guerrant, R. L., Ramakrishna, B., Tannock, G. W., & Versalovic, J. A. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.11.010 · Cited by 156
Johnson, T. J., Logue, C. M., Johnson, J. R., Kuskowski, M. A., Sherwood, J. S., Barnes, H. J., DebRoy, C., Wannemuehler, Y. M., Obata‐Yasuoka, M., Spanjaard, L., et al. (2011) · Foodborne Pathogens and Disease · doi:10.1089/fpd.2011.0961 · Cited by 154
Effect of Probiotics on Intestinal Barrier Function
Mennigen, R. B., & Bruewer, M. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04059.x · Cited by 153
Mugnaioli, C., Luzzaro, F., Luca, F. D., Brigante, G., Perilli, M., Amicosante, G., Stefani, S., Toniolo, A., & Rossolini, G. M. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00068-06 · Cited by 153
Enteroaggregative Escherichia coli: epidemiology, virulence and detection
Weintraub, A. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46930-0 · Cited by 151
Pouillot, F., Chomton, M., Blois, H., Courroux, C., Noelig, J., Bidet, P., Bingen, É., & Bonacorsi, S. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06330-11 · Cited by 145
Multiresistant Enterobacteriaceae: new threat of an old problem
Pitout, J. D. D. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.5.657 · Cited by 141
Enterohemorrhagic Escherichia coli O26:H11/H−: A New Virulent Clone Emerges in Europe
Bielaszewska, M., Mellmann, A., Bletz, S., Zhang, W., Köck, R., Kossow, A., Prager, R., Fruth, A., Orth‐Höller, D., Marejková, M., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit055 · Cited by 140
Lytic infection ofEscherichia colibiofilms by bacteriophage T4
Doolittle, M. M., Cooney, J. J., & Caldwell, D. E. (1995) · Canadian Journal of Microbiology · doi:10.1139/m95-002 · Cited by 138
Pini, A., Giuliani, A., Falciani, C., Runci, Y., Ricci, C., Lelli, B., Malossi, M., Neri, P., Rossolini, G. M., & Bracci, L. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.2665-2672.2005 · Cited by 134
Transferable mechanisms of quinolone resistance
Ruiz, J., Pons, M. J., & Gomes, C. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.02.011 · Cited by 132
Bacteriophages with the Ability to Degrade Uropathogenic Escherichia Coli Biofilms
Chibeu, A., Lingohr, E. J., Masson, L., Manges, A. R., Harel, J., Ackermann, H.-W., Kropinski, A. M., & Boerlin, P. (2012) · Viruses · doi:10.3390/v4040471 · Cited by 122
Negroni, A., Costanzo, M., Vitali, R., Superti, F., Bertuccini, L., Tinari, A., Minelli, F., Nardo, G. D., Nuti, F., Pierdomenico, M., et al. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21899 · Cited by 113
Recent trends in antibiotic resistance in European ICUs
van Duijn, P. J., Dautzenberg, M. J. D., & Oostdijk, E. A. N. (2011) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e32834c9d87 · Cited by 112
Platell, J. L., Johnson, J. R., Cobbold, R. N., & Trott, D. J. (2011) · Veterinary Microbiology · doi:10.1016/j.vetmic.2011.05.007 · Cited by 111
Virulent Bacteriophages Can Target O104:H4 Enteroaggregative Escherichia coli in the Mouse Intestine
Maura, D., Galtier, M., Bouguénec, C. L., & Debarbieux, L. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00602-12 · Cited by 104
Probiotic Therapy: Immunomodulating Approach Toward Urinary Tract Infection
Amdekar, S., Singh, V. K., & Singh, D. D. (2011) · Current Microbiology · doi:10.1007/s00284-011-0006-2 · Cited by 103
Hendriksen, R. S., Mevius, D. J., Schroeter, A., Teale, C. J., Jouy, É., Butaye, P., Franco, A., Utināne, A., Amado, A., Moreno, M. Á., et al. (2008) · Acta veterinaria Scandinavica · doi:10.1186/1751-0147-50-19 · Cited by 92
The Importance and Future of Antimicrobial Surveillance Studies
Masterton, R. G. (2008) · Clinical Infectious Diseases · doi:10.1086/590063 · Cited by 88
Niu, Y. D., Stanford, K., Kropinski, A. M., Ackermann, H. W., Johnson, R. P., She, Y., Ahmed, R., Villegas, A., & McAllister, T. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034585 · Cited by 86
Ecology of antimicrobial resistance: humans, animals, food and environment.
González‐Zorn, B., & Escudero, J. A. (2012) · PubMed · doi:10.2436/20.1501.01.163 · Cited by 84
Understanding efflux in Gram-negative bacteria: opportunities for drug discovery
Schweizer, H. P. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.688949 · Cited by 84
Hasdemir, U. O., Gür, D., Ünal, S., & Miller, G. H. (2001) · Clinical Microbiology and Infection · doi:10.1046/j.1198-743x.2001.00284.x · Cited by 63
Merabishvili, M., Vos, D. D., Verbeken, G., Kropinski, A. M., Vandenheuvel, D., Lavigne, R., Wattiau, P., Mast, J., Ragimbeau, C., Mossong, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052709 · Cited by 59
Balode, A. O., Punda-Polić, V., & Dowzicky, M. J. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.02.022 · Cited by 59
Thorsteinsdottir, T. R., Haraldsson, G., Friðriksdóttir, V., Kristinsson, K. G., & Gunnarsson, E. (2009) · Zoonoses and Public Health · doi:10.1111/j.1863-2378.2009.01256.x · Cited by 50
CTX-M-15-producing Escherichia coli in fatal neonatal meningitis: failure of empirical chemotherapy
Boyer-Mariotte, S., Duboc, P., Bonacorsi, S., Lemeland, J. F., Bingen, É., & Pinquier, D. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn362 · Cited by 45
Mielke, M. E. A. (2010) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2010.04.004 · Cited by 42
Yoon, S. H., Jeong, H., Kwon, S.-K., & Kim, J. F. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9394-4_1 · Cited by 38
Lindemann, P. C., Risberg, K., Wiker, H. G., & Mylvaganam, H. (2011) · Apmis · doi:10.1111/j.1600-0463.2011.02856.x · Cited by 37
First detection of VIM-4 metallo-β-lactamase-producing Escherichia coli in Russia
Shevchenko, O. V., Mudrak, D. Y., Skleenova, E. Y., Kozyreva, V. K., Ilina, E. N., Ikryannikova, L. N., Alexandrova, I. A., Sv, S., & Edelstein, M. V. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03827.x · Cited by 25
Zarubica, T., Baker, M. R., Wright, H. T., & Rife, J. P. (2010) · RNA · doi:10.1261/rna.2314311 · Cited by 21
Discovery of potent antimicrobial peptide analogs of Ixosin-B
Lung, F. T., Wang, K.-S., Liao, Z.-J., Hsu, S.-K., Song, F.-Y., Liou, C., & Wu, Y. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.04.018 · Cited by 15
Biliński, P., Kapka‐Skrzypczak, L., Posobkiewicz, M., Bondaryk, M., Hołownia, P., & Wojtyła, A. (2012) · PubMed · Cited by 13
High Prevalence of CTX-M-15-Producing O25b-ST131 Escherichia coli Clone in Bulgarian Hospitals
Markovska, R. D., Schneider, I., Ivanova, D., Keuleyan, E. E., Stoeva, T., Sredkova, M., Markova, B., Bojkova, K., Gergova, R. T., Bauernfeind, A., et al. (2012) · Microbial Drug Resistance · doi:10.1089/mdr.2011.0186 · Cited by 9
Bedenić, B., Vraneš, J., Hofmann-Thiel, S., Tonkić, M., Novak, A., Bučević‐Popović, V., & Hoffmann, H. (2012) · Wiener klinische Wochenschrift · doi:10.1007/s00508-012-0210-5 · Cited by 7
Cited by
Meier-Kolthoff, J. P., Hahnke, R. L., Petersen, J., Scheuner, C., Michael, V., Fiebig, A., Rohde, C., Rohde, M., Fartmann, B., Goodwin, L. A., et al. (2014) · Standards in Genomic Sciences · doi:10.1186/1944-3277-9-2 · Cited by 620
Copper as an antimicrobial agent: recent advances
Salah, I., Parkin, I. P., & Allan, E. (2021) · RSC Advances · doi:10.1039/d1ra02149d · Cited by 453
Die for the community: an overview of programmed cell death in bacteria
Allocati, N., Masulli, M., Di Ilio, C., & De Laurenzi, V (2015) · Cell Death & Disease · doi:10.1038/cddis.2014.570 · Cited by 290
Self-citation
Metadata
- Authors
- Allocati, N., Masulli, M., Alexeyev, M., & Di Ilio, C.
- Venue
- International Journal of Environmental Research and Public Health
- Publisher
- MDPI AG
- Published
- 2013-11-25
- Volume
- 10
- Issue
- 12
- Pages
- 6235-6254
- ISSN
- 1660-4601 (ISSN-L)
- OpenAlex
- W2019779784
- Cited by
- 471
- References
- 99
- FWCI
- 9.34
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.